No Photo Available

Last Update

2014-04-19T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Didier Reymond?

Dr. Didier Reymond

Executive Vice President, Clinical Development

Crescita Therapeutics Inc

HQ Phone: (403) 474-4661

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Crescita Therapeutics Inc

120 3510 - 29Th Street Ne

Calgary, Alberta T1Y 7E5

Canada

Company Description

Search the Canadian Life Sciences Database and identify potential partners in the Canadian Biotech, Pharma and Medtech industry ... more

Find other employees at this company (7)

Background Information

Employment History

Executive Vice President, Clinical Development

Thallion Pharmaceuticals Inc.

Executive Vice President Clinical Development

Ecopia BioSciences Inc.

Education

Lausanne University , Medical School

MD

Web References (5 Total References)


Dr. Didier ...

www.canadianlifesciences.com [cached]

Dr. Didier Reymond Executive Vice-President, Clinical Development dreymond@thallion.com


Management : Thallion Pharmaceuticals

www.ecopiabio.com [cached]

Didier Reymond, MD

Executive Vice-President, Clinical Development
Dr. Reymond leads clinical development for all phases ofThallion's clinicalprograms. Before Thallion, he was a Senior Medical Advisorwith Novartis Canada, leading the medical and clinical activities for solid tumors. Prior to that, Dr. Reymond was Associate Director, Scientific Affairs, for the Merck Vaccine Division, Merck Frosst Canada. He was responsible for Regulatory Affairs and Medical Affairs for all vaccines in Canada. Dr. Reymond graduated from Lausanne University, Medical School,before working in Pediatric Surgery and completing his residency in Pediatrics at the University Hospitals of Lausanne and Bern.Board certified in Pediatrics, Dr. Reymond pursued a Fellowship in Pediatric Infectious Diseases at The Hospital for Sick Children, Toronto, where he conducted research activities on Verotoxin-producing Escherichia coli. Dr. Reymond completed his fellowship program at the Hôpital Sainte-Justine, in Montreal, conducting pediatric clinical research focusing on oral antibiotics.


Didier Reymond VP ...

www.arena-international.com [cached]

Didier Reymond VP Clinical Development Thallion Pharmaceuticals


Didier Reymond, MD ...

www.canadianskin.ca [cached]

Didier Reymond, MD 514-228-3631 dreymond@thallion.com


Press Releases : Thallion Pharmaceuticals

www.ecopiabio.com [cached]

Thallion also announced the promotion of Dr. Didier Reymond to Executive Vice President Clinical Development. Dr. Reymond will assume the leadership of all Thallion's clinical and regulatory operations.

Similar Profiles

Other People with this Name

Other people with the name Reymond

Thibault Reymond
Dethomas Peltier Juvigny & Associés

Marc Reymond
Thermo Fisher Scientific Inc.

Christine Reymond
Gerald Group

Vanessa Reymond
Vistra Limited

Philippe Reymond
HEC Montréal

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory